Health risks related to polyurethane foam degradation in CPAP devices used for sleep apnoea treatment

Patients with PUF-CPAP and especially those with pre-existing obstructive lung disease had increased use of anti-obstructive medication but there were no differences in hospitalisations and mortality, and data on cancer were inconclusive https://bit.ly/3uVIzXG

Detalles Bibliográficos
Autores principales: Palm, Andreas, Grote, Ludger, Ekström, Magnus, Ljunggren, Mirjam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Agora
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117731/
https://www.ncbi.nlm.nih.gov/pubmed/35144995
http://dx.doi.org/10.1183/13993003.00237-2022
_version_ 1784710375000768512
author Palm, Andreas
Grote, Ludger
Ekström, Magnus
Ljunggren, Mirjam
author_facet Palm, Andreas
Grote, Ludger
Ekström, Magnus
Ljunggren, Mirjam
author_sort Palm, Andreas
collection PubMed
description Patients with PUF-CPAP and especially those with pre-existing obstructive lung disease had increased use of anti-obstructive medication but there were no differences in hospitalisations and mortality, and data on cancer were inconclusive https://bit.ly/3uVIzXG
format Online
Article
Text
id pubmed-9117731
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-91177312022-05-20 Health risks related to polyurethane foam degradation in CPAP devices used for sleep apnoea treatment Palm, Andreas Grote, Ludger Ekström, Magnus Ljunggren, Mirjam Eur Respir J Agora Patients with PUF-CPAP and especially those with pre-existing obstructive lung disease had increased use of anti-obstructive medication but there were no differences in hospitalisations and mortality, and data on cancer were inconclusive https://bit.ly/3uVIzXG European Respiratory Society 2022-05-19 /pmc/articles/PMC9117731/ /pubmed/35144995 http://dx.doi.org/10.1183/13993003.00237-2022 Text en Copyright ©The authors 2022. https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org)
spellingShingle Agora
Palm, Andreas
Grote, Ludger
Ekström, Magnus
Ljunggren, Mirjam
Health risks related to polyurethane foam degradation in CPAP devices used for sleep apnoea treatment
title Health risks related to polyurethane foam degradation in CPAP devices used for sleep apnoea treatment
title_full Health risks related to polyurethane foam degradation in CPAP devices used for sleep apnoea treatment
title_fullStr Health risks related to polyurethane foam degradation in CPAP devices used for sleep apnoea treatment
title_full_unstemmed Health risks related to polyurethane foam degradation in CPAP devices used for sleep apnoea treatment
title_short Health risks related to polyurethane foam degradation in CPAP devices used for sleep apnoea treatment
title_sort health risks related to polyurethane foam degradation in cpap devices used for sleep apnoea treatment
topic Agora
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117731/
https://www.ncbi.nlm.nih.gov/pubmed/35144995
http://dx.doi.org/10.1183/13993003.00237-2022
work_keys_str_mv AT palmandreas healthrisksrelatedtopolyurethanefoamdegradationincpapdevicesusedforsleepapnoeatreatment
AT groteludger healthrisksrelatedtopolyurethanefoamdegradationincpapdevicesusedforsleepapnoeatreatment
AT ekstrommagnus healthrisksrelatedtopolyurethanefoamdegradationincpapdevicesusedforsleepapnoeatreatment
AT ljunggrenmirjam healthrisksrelatedtopolyurethanefoamdegradationincpapdevicesusedforsleepapnoeatreatment

Ejemplares similares